Imperial College London

Jeff Eaton

Faculty of MedicineSchool of Public Health

Senior Lecturer in HIV Epidemiology







Norfolk PlaceSt Mary's Campus






BibTex format

author = {Nabukalu, D and Reniers, G and Risher, KA and Blom, S and Slaymaker, E and Kabudula, C and Zaba, B and Nalugoda, F and Kigodzi, G and Makumbi, F and Serwadda, D and Reynolds, SJ and Marston, M and Eaton, J and Gray, R and Wawer, M and Sewankambo, N and Lutalo, T},
doi = {10.1080/00324728.2019.1595099},
journal = {Population Studies},
pages = {93--102},
title = {Population-level adult mortality following the expansion of antiretroviral therapy in Rakai, Uganda},
url = {},
volume = {74},
year = {2019}

RIS format (EndNote, RefMan)

AB - There are limited data on the impact of antiretroviral therapy (ART) on population-level adult mortality in sub-Saharan Africa. We analysed data for 2000–14 from the Rakai Community Cohort Study (RCCS) in Uganda, where free ART was scaled up after 2004. Using non-parametric and parametric (Weibull) survival analysis, we estimated trends in average person-years lived between exact ages 15 and 50, per capita life-years lost to HIV, and the mortality hazards of people living with HIV (PLHIV). Between 2000 and 2014, average adult life-years lived before age 50 increased significantly, from 26.4 to 33.5 years for all women and from 28.6 to 33.8 years for all men. As of 2014, life-years lost to HIV had declined significantly, to 1.3 years among women and 0.4 years among men. Following the roll-out of ART, mortality reductions among PLHIV were initially larger in women than men, but this is no longer the case
AU - Nabukalu,D
AU - Reniers,G
AU - Risher,KA
AU - Blom,S
AU - Slaymaker,E
AU - Kabudula,C
AU - Zaba,B
AU - Nalugoda,F
AU - Kigodzi,G
AU - Makumbi,F
AU - Serwadda,D
AU - Reynolds,SJ
AU - Marston,M
AU - Eaton,J
AU - Gray,R
AU - Wawer,M
AU - Sewankambo,N
AU - Lutalo,T
DO - 10.1080/00324728.2019.1595099
EP - 102
PY - 2019///
SN - 0032-4728
SP - 93
TI - Population-level adult mortality following the expansion of antiretroviral therapy in Rakai, Uganda
T2 - Population Studies
UR -
UR -
UR -
VL - 74
ER -